Optimise viewing for

Toggle between patient and health professional views. The patient version is simplified to help people easily find suitable trials, while the professional view provides full detail.

RecruitingLast updated: 9 October 2025

ChemoFit: A study for people with stage I-III solid cancers who are planned to receive chemotherapy that is testing whether exercise during treatment has a beneficial effectThe effect of exercise on chemotherapy completion rates in adult cancer patients with solid tumours receiving adjuvant chemotherapy

Trial purpose

Medical clipboardCancer treatment; Side effect and wellbeing

Tumor type

Multi-Cancer Multi-Cancer

Age

People18+

Trial acronym

ChemoFit

Clinical summary

Summary

This study aims to explore whether participating in exercise during adjuvant chemotherapy can improve treatment tolerance and more specfically chemotherapy completion rates.

You may be eligible for this study if you are aged 18 years or older, have been diagnosed with a stage I-III solid tumour and are scheduled to receive chemotherapy.

Participants will be offered twice-weekly supervised small group exercise sessions for the duration of their adjuvant chemotherapy, or for a maximum of 8 months. Exercise sessions will last approximately 60 minutes and involve a combination of aerobic, resistance, and balance exercises. Participants will also be encouraged to engage in additional aerobic exercises at home with the goal of a total of at least 150 minutes of moderate to vigorous intensity aerobic exercise each week.

Data on chemotherapy completion, physical and mental wellbing will be collected before, during and after the intervention.

It is hoped that information from this study will help determine whether participating in exercise during adjuvant chemotherapy has a beneficial effect on chemotherapy completion rates and physical and mental wellbing in people diagnosed with cancer. 

 

Conditions

This trial is treating people with solid cancers who are planning to receive first-line adjuvant chemotherapy

Eligibility

Inclusion

1) Diagnosed with a solid tumour (stages I-III),
2) Scheduled for first-line adjuvant chemotherapy with curative intent,
3) Eastern Cooperative Oncology Group (ECOG) Performance Status 0-2,
4) Greater than or equal to 18 years of age.

Exclusion

 

1) Other actively treated cancer (expect for non-melanoma skin cancer),
2) Having received chemotherapy previously,
3) Any medical condition that could place the participant at unreasonable risk of injury or illness caused by the exercise testing or training;
4) Pregnant
5) Unable to read, speak or understand English (and no interpreter).

Inclusion

  • You have the type of cancer, symptoms, or health risks that this clinical trial is focused on.

Exclusion

  • You have been diagnosed with a prior or secondary type of cancer.
  • You have certain types of non-cancer medical conditions.
  • You have had certain treatments, surgical procedures or drugs.
Message

Clinical trials have complex eligibility criteria, and other criteria may apply for this trial. Ask your doctor about whether this trial could be right for you.

Participating hospitals

Recruiting hospitals

InformationTell us if you find this trial availability is not accurate.Report inaccuracy

More information

Trial Identifiers

Information on this page is partially produced from ANZCTR *. View further details about this trial on the registry via the links below:

Trial sponsor

Cabrini Health

Scientific Title

The effect of exercise on chemotherapy completion rates in adult cancer patients with solid tumours receiving adjuvant chemotherapy

Get Support

Peer Connect

You might find it helpful to speak to someone who has 'been there before'. Our Peer Connect program can provide one-on-one phone support from someone who understands what you're going through and has clinical trials experience.

Know more about Peer Connect

Contact cancer support

If you need cancer information and practical support for yourself, a carer, family or friend, contact Cancer Council to speak with an experienced health professional on 13 11 20.

Get support

Multilingual information

Learn more about clinical trials through this collection of resources in languages other than English.

View information